Intensive care unit-acquired infection as a side effect of sedation

Critical Care

Volumn 14, Issue 2, 2010, Pages

  Nseir, Saad ^a   Makris, Demosthenes ^b   Mathieu, Daniel ^a   Durocher, Alain ^a   Marquette, Charles Hugo ^c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^c UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CLONIDINE; DEXMEDETOMIDINE; DIAZEPAM; MIDAZOLAM; OPIATE DERIVATIVE; PROPOFOL; SEDATIVE AGENT;

ANALGESIA; ARTICLE; ARTIFICIAL VENTILATION; ASPIRATION; BIBLIOGRAPHIC DATABASE; BLOODSTREAM INFECTION; CELLULAR IMMUNITY; CHEMOTAXIS; CRITICALLY ILL PATIENT; DRUG EXPOSURE; GASTROINTESTINAL MOTILITY DISORDER; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION RATE; INFECTION RISK; INNATE IMMUNITY; MEDLINE; MICROASPIRATION; MICROCIRCULATION; NAUSEA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SEDATION; SIDE EFFECT; VENTILATOR ASSOCIATED PNEUMONIA; VOMITING; CROSS INFECTION; DEEP SEDATION; INTENSIVE CARE UNIT; REVIEW; RISK ASSESSMENT;

CROSS INFECTION; DEEP SEDATION; HUMANS; INTENSIVE CARE UNITS; RISK ASSESSMENT;

EID: 77949447770     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8907     Document Type: Article

References (151)

1. Burke JP. Infection control - a problem for patient safety. N Engl J Med 2003, 348:651-656. 10.1056/NEJMhpr020557, 12584377.
2. Hugonnet S, Uckay I, Pittet D. Staffing level: a determinant of late-onset ventilator-associated pneumonia. Crit Care 2007, 11:R80. 10.1186/cc5974, 2206525, 17640384.
3. Malacarne P, Langer M, Nascimben E, Moro ML, Giudici D, Lampati L, Bertolini G. Building a continuous multicenter infection surveillance system in the intensive care unit: findings from the initial data set of 9,493 patients from 71 Italian intensive care units. Crit Care Med 2008, 36:1105-1113. 10.1097/CCM.0b013e318169ed30, 18379234.
4. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34:344-353. 10.1097/01.CCM.0000194725.48928.3A, 16424713.
5. Nseir S, Di Pompeo C, Soubrier S, Cavestri B, Jozefowicz E, Saulnier F, Durocher A. Impact of ventilator-associated pneumonia on outcome in patients with COPD. Chest 2005, 128:1650-1656. 10.1378/chest.128.3.1650, 16162771.
6. Safdar N, Abad C. Educational interventions for prevention of healthcare-associated infection: a systematic review. Crit Care Med 2008, 36:933-940. 10.1097/CCM.0B013E318165FAF3, 18431283.
7. Tacconelli E, De Angelis G. Pneumonia due to methicillin-resistant Staphylococcus aureus: clinical features, diagnosis and management. Curr Opin Pulm Med 2009, 15:218-222. 10.1097/MCP.0b013e3283292666, 19373090.
8. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416. 10.1164/rccm.200405-644ST, 15699079.
9. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005, 33:2184-2193. 10.1097/01.CCM.0000181731.53912.D9, 16215368.
10. Ylipalosaari P, Ala-Kokko TI, Laurila J, Ohtonen P, Syrjala H. Intensive care unit acquired infection has no impact on long-term survival or quality of life: a prospective cohort study. Crit Care 2007, 11:R35. 10.1186/cc5718, 2206451, 17346355.
11. Sessler CN, Varney K. Patient-focused sedation and analgesia in the ICU. Chest 2008, 133:552-565. 10.1378/chest.07-2026, 18252923.
12. Richman PS, Baram D, Varela M, Glass PS. Sedation during mechanical ventilation: a trial of benzodiazepine and opiate in combination. Crit Care Med 2006, 34:1395-1401. 10.1097/01.CCM.0000215454.50964.F8, 16540957.
13. Mehta S, Burry L, Fischer S, Martinez-Motta JC, Hallett D, Bowman D, Wong C, Meade MO, Stewart TE, Cook DJ. Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients. Crit Care Med 2006, 34:374-380. 10.1097/01.CCM.0000196830.61965.F1, 16424717.
14. Muellejans B, Matthey T, Scholpp J, Schill M. Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial. Crit Care 2006, 10:R91. 10.1186/cc4939, 1550941, 16780597.
15. Rozendaal FW, Spronk PE, Snellen FF, Schoen A, van Zanten AR, Foudraine NA, Mulder PG, Bakker J. Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands. Intensive Care Med 2009, 35:291-298. 10.1007/s00134-008-1328-9, 18949456.
16. Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest 1998, 114:541-548. 10.1378/chest.114.2.541, 9726743.
17. Arroliga A, Frutos-Vivar F, Hall J, Esteban A, Apezteguia C, Soto L, Anzueto A. Use of sedatives and neuromuscular blockers in a cohort of patients receiving mechanical ventilation. Chest 2005, 128:496-506. 10.1378/chest.128.2.496, 16100131.
18. Sessler CN, Wilhelm W. Analgesia and sedation in the intensive care unit: an overview of the issues. Crit Care 2008, 12(Suppl 3):S1. 2391267, 18495052.
19. Schweickert WD, Kress JP. Strategies to optimize analgesia and sedation. Crit Care 2008, 12(Suppl 3):S6. 2391265, 18495057.
20. Soliman HM, Melot C, Vincent JL. Sedative and analgesic practice in the intensive care unit: the results of a European survey. Br J Anaesth 2001, 87:186-192. 10.1093/bja/87.2.186, 11493487.
21. Payen JF, Chanques G, Mantz J, Hercule C, Auriant I, Leguillou JL, Binhas M, Genty C, Rolland C, Bosson JL. Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology 2007, 106:687-695. 10.1097/01.anes.0000264747.09017.da, 17413906.
22. Schwacha MG, McGwin G, Hutchinson CB, Cross JM, Maclennan PA, Rue LW. The contribution of opiate analgesics to the development of infectious complications in burn patients. Am J Surg 2006, 192:82-86. 10.1016/j.amjsurg.2006.01.001, 16769281.
23. Metheny NA, Clouse RE, Chang YH, Stewart BJ, Oliver DA, Kollef MH. Tracheobronchial aspiration of gastric contents in critically ill tube-fed patients: frequency, outcomes, and risk factors. Crit Care Med 2006, 34:1007-1015. 10.1097/01.CCM.0000206106.65220.59, 2396145, 16484901.
24. Nseir S, Hoel J, Grailles G, Soury-Lavergne A, Di Pompeo C, Mathieu D, Durocher A. Remifentanil discontinuation and subsequent intensive care unit-acquired infection: a cohort study. Crit Care 2009, 13:R60. 10.1186/cc7788, 2689508, 19383164.
25. Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, Jaeschke RZ, Brun-Buisson C. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998, 129:433-440.
26. Kooi TI, de Boer AS, Mannien J, Wille JC, Beaumont MT, Mooi BW, van den HS. Incidence and risk factors of device-associated infections and associated mortality at the intensive care in the Dutch surveillance system. Intensive Care Med 2007, 33:271-278. 10.1007/s00134-006-0464-3, 17146632.
27. Hugonnet S, Chevrolet JC, Pittet D. The effect of workload on infection risk in critically ill patients. Crit Care Med 2007, 35:76-81. 10.1097/01.CCM.0000251125.08629.3F, 17095946.
28. Akca O, Koltka K, Uzel S, Cakar N, Pembeci K, Sayan MA, Tutuncu AS, Karakas SE, Calangu S, Ozkan T, Esen F, Telci L, Sessler DI, Akpir K. Risk factors for early-onset, ventilator-associated pneumonia in critical care patients: selected multiresistant versus nonresistant bacteria. Anesthesiology 2000, 93:638-645. 10.1097/00000542-200009000-00011, 10969295.
29. Bornstain C, Azoulay E, De Lassence A, Cohen Y, Costa MA, Mourvillier B, Descorps-Declere A, Garrouste-Org, Thuong M, Schlemmer B, Timsit JF. Sedation, sucralfate, and antibiotic use are potential means for protection against early-onset ventilator-associated pneumonia. Clin Infect Dis 2004, 38:1401-1408. 10.1086/386321, 15156478.
30. Nseir S, Di Pompeo C, Jozefowicz E, Cavestri B, Brisson H, Nyunga M, Soubrier S, Durocher A. Relationship between tracheotomy and ventilator-associated pneumonia: a case control study. Eur Respir J 2007, 30:314-320. 10.1183/09031936.06.00024906, 16870667.
31. Alp E, Guven M, Yildiz O, Aygen B, Voss A, Doganay M. Incidence, risk factors and mortality of nosocomial pneumonia in intensive care units: a prospective study. Ann Clin Microbiol Antimicrob 2004, 3:17. 10.1186/1476-0711-3-17, 521500, 15369593.
32. Craven DE. Preventing ventilator-associated pneumonia in adults: sowing seeds of change. Chest 2006, 130:251-260. 10.1378/chest.130.1.251, 16840410.
33. Safdar N, Crnich CJ, Maki DG. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care 2005, 50:725-739.
34. Kolbel CB, Rippel K, Klar H, Singer MV, van Ackern K, Fiedler F. Esophageal motility disorders in critically ill patients: a 24-hour manometric study. Intensive Care Med 2000, 26:1421-1427. 10.1007/s001340000630, 11126251.
35. Lamblin V, Favory R, Boulo M, Mathieu D. Microcirculatory alterations induced by sedation in intensive care patients. Effects of midazolam alone and in association with sufentanil. Crit Care 2006, 10:R176. 10.1186/cc5128, 1794492, 17173680.
36. De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002, 166:98-104. 10.1164/rccm.200109-016OC, 12091178.
37. Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004, 32:1825-1831. 10.1097/01.CCM.0000138558.16257.3F, 15343008.
38. Tsai AG, Cabrales P, Winslow RM, Intaglietta M. Microvascular oxygen distribution in awake hamster window chamber model during hyperoxia. Am J Physiol Heart Circ Physiol 2003, 285:H1537-H1545.
39. Neviere R, Mathieu D, Chagnon JL, Lebleu N, Millien JP, Wattel F. Skeletal muscle microvascular blood flow and oxygen transport in patients with severe sepsis. Am J Respir Crit Care Med 1996, 153:191-195.
40. Fruhwald S, Holzer P, Metzler H. Intestinal motility disturbances in intensive care patients pathogenesis and clinical impact. Intensive Care Med 2007, 33:36-44. 10.1007/s00134-006-0452-7, 17115132.
41. Spoel JI, Oudemans-van Straaten HM, Kuiper MA, van Roon EN, Zandstra DF, Voort PH. Laxation of critically ill patients with lactulose or polyethylene glycol: a two-center randomized, double-blind, placebo-controlled trial. Crit Care Med 2007, 35:2726-2731. 10.1097/01.CCM.0000287526.08794.29, 17893628.
42. Husebye E. Gastrointestinal motility disorders and bacterial overgrowth. J Intern Med 1995, 237:419-427. 10.1111/j.1365-2796.1995.tb01196.x, 7714466.
43. Haglund U. Systemic mediators released from the gut in critical illness. Crit Care Med 1993, 21:S15-S18.
44. Ritz MA, Fraser R, Tam W, Dent J. Impacts and patterns of disturbed gastrointestinal function in critically ill patients. Am J Gastroenterol 2000, 95:3044-3052. 10.1111/j.1572-0241.2000.03176.x, 11095317.
45. Sternini C, Patierno S, Selmer IS, Kirchgessner A. The opioid system in the gastrointestinal tract. Neurogastroenterol Motil 2004, 16(Suppl 2):3-16. 10.1111/j.1743-3150.2004.00553.x, 15357847.
46. Walsh TD. Prevention of opioid side effects. J Pain Symptom Manage 1990, 5:362-367. 10.1016/0885-3924(90)90031-E, 1980127.
47. Herbert MK, Roth-Goldbrunner S, Holzer P, Roewer N. Clonidine and dexmedetomidine potently inhibit peristalsis in the Guinea pig ileum in vitro. Anesthesiology 2002, 97:1491-1499. 10.1097/00000542-200212000-00022, 12459676.
48. Freye E, Sundermann S, Wilder-Smith OH. No inhibition of gastro-intestinal propulsion after propofol- or propofol/ketamine-N2O/O2 anaesthesia. A comparison of gastro-caecal transit after isoflurane anaesthesia. Acta Anaesthesiol Scand 1998, 42:664-669. 10.1111/j.1399-6576.1998.tb05299.x, 9689272.
49. Asakura H, Kawamoto K, Igimi S, Yamamoto S, Makino S. Enhancement of mice susceptibility to infection with Listeria monocytogenes by the treatment of morphine. Microbiol Immunol 2006, 50:543-547.
50. Wang J, Barke RA, Charboneau R, Roy S. Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection. J Immunol 2005, 174:426-434.
51. Hilburger ME, Adler MW, Truant AL, Meissler JJ, Satishchandran V, Rogers TJ, Eisenstein TK. Morphine induces sepsis in mice. J Infect Dis 1997, 176:183-188. 10.1086/514021, 9207365.
52. Olin MR, Choi K, Lee J, Peterson PK, Molitor TW. Morphine modulates gammadelta lymphocytes cytolytic activity following BCG vaccination. Brain Behav Immun 2007, 21:195-201. 10.1016/j.bbi.2006.06.003, 16870392.
53. Chao CC, Sharp BM, Pomeroy C, Filice GA, Peterson PK. Lethality of morphine in mice infected with Toxoplasma gondii. J Pharmacol Exp Ther 1990, 252:605-609.
54. Di Francesco P, Gaziano R, Casalinuovo IA, Palamara AT, Favalli C, Garaci E. Antifungal and immunoadjuvant properties of fluconazole in mice immunosuppressed with morphine. Chemotherapy 1997, 43:198-203. 10.1159/000239561, 9142461.
55. Hu S, Sheng WS, Lokensgard JR, Peterson PK. Morphine potentiates HIV-1 gp120-induced neuronal apoptosis. J Infect Dis 2005, 191:886-889. 10.1086/427830, 15717263.
56. Bayer BM, Daussin S, Hernandez M, Irvin L. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology 1990, 29:369-374. 10.1016/0028-3908(90)90096-A, 2160624.
57. Bayer BM, Gastonguay MR, Hernandez MC. Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility. Immunopharmacology 1992, 23:117-124. 10.1016/0162-3109(92)90035-B, 1601640.
58. Shavit Y, Lewis JW, Terman GW, Gale RP, Liebeskind JC. Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 1984, 223:188-190. 10.1126/science.6691146, 6691146.
59. Bussiere JL, Adler MW, Rogers TJ, Eisenstein TK. Differential effects of morphine and naltrexone on the antibody response in various mouse strains. Immunopharmacol Immunotoxicol 1992, 14:657-673. 10.3109/08923979209005416, 1517538.
60. West JP, Lysle DT, Dykstra LA. Tolerance development to morphine-induced alterations of immune status. Drug Alcohol Depend 1997, 46:147-157. 10.1016/S0376-8716(97)00059-8, 9250473.
61. Tubaro E, Borelli G, Croce C, Cavallo G, Santiangeli C. Effect of morphine on resistance to infection. J Infect Dis 1983, 148:656-666.
62. Rojavin M, Szabo I, Bussiere JL, Rogers TJ, Adler MW, Eisenstein TK. Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. Life Sci 1993, 53:997-1006. 10.1016/0024-3205(93)90122-J, 8361330.
63. Malik AA, Radhakrishnan N, Reddy K, Smith AD, Singhal PC. Morphine-induced macrophage apoptosis modulates migration of macrophages: use of in vitro model of urinary tract infection. J Endourol 2002, 16:605-610. 10.1089/089277902320913314, 12470470.
64. Lysle DT, Coussons ME, Watts VJ, Bennett EH, Dykstra LA. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J Pharmacol Exp Ther 1993, 265:1071-1078.
65. Gomez-Flores R, Weber RJ. Inhibition of interleukin-2 production and downregulation of IL-2 and transferrin receptors on rat splenic lymphocytes following PAG morphine administration: a role in natural killer and T cell suppression. J Interferon Cytokine Res 1999, 19:625-630. 10.1089/107999099313767, 10433363.
66. Gomez-Flores R, Suo JL, Weber RJ. Suppression of splenic macrophage functions following acute morphine action in the rat mesencephalon periaqueductal gray. Brain Behav Immun 1999, 13:212-224. 10.1006/brbi.1999.0563, 10469523.
67. Nelson CJ, How T, Lysle DT. Enhancement of the contact hypersensitivity reaction by acute morphine administration at the elicitation phase. Clin Immunol 1999, 93:176-183. 10.1006/clim.1999.4783, 10527694.
68. Singh PP, Singal P. Morphine-induced neuroimmunomodulation in murine visceral leishmaniasis: the role(s) of cytokines and nitric oxide. J Neuroimmune Pharmacol 2007, 2:338-351. 10.1007/s11481-007-9094-y, 18040852.
69. Jamali A, Bamdad T, Soleimanjahi H, Pakdel FG, Arefian E. Acute morphine administration reduces white blood cells' capability to induce innate resistance against HSV-1 infection in BALB/c mice. Neuroimmunomodulation 2007, 14:16-23. 10.1159/000107284, 17700036.
70. Li Y, Ye L, Peng JS, Wang CQ, Luo GX, Zhang T, Wan Q, Ho WZ. Morphine inhibits intrahepatic interferon- alpha expression and enhances complete hepatitis C virus replication. J Infect Dis 2007, 196:719-730. 10.1086/520093, 17674315.
71. Brand JM, Frohn C, Luhm J, Kirchner H, Schmucker P. Early alterations in the number of circulating lymphocyte subpopulations and enhanced proinflammatory immune response during opioid-based general anesthesia. Shock 2003, 20:213-217. 10.1097/00024382-200309000-00003, 12923491.
72. Chao CC, Gekker G, Sheng WS, Hu S, Tsang M, Peterson PK. Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression. J Pharmacol Exp Ther 1994, 269:198-203.
73. Carr DJ. The role of endogenous opioids and their receptors in the immune system. Proc Soc Exp Biol Med 1991, 198:710-720.
74. Caroleo MC, Arbitrio M, Melchiorri D, Nistico G. A reappraisal of the role of the various opioid receptor subtypes in cell-mediated immunity. Neuroimmunomodulation 1994, 1:141-147. 10.1159/000097148, 7489325.
75. Bidlack JM. Detection and function of opioid receptors on cells from the immune system. Clin Diagn Lab Immunol 2000, 7:719-723. 95944, 10973443.
76. McCarthy L, Wetzel M, Sliker JK, Eisenstein TK, Rogers TJ. Opioids, opioid receptors, and the immune response. Drug Alcohol Depend 2001, 62:111-123. 10.1016/S0376-8716(00)00181-2, 11245967.
77. Fecho K, Maslonek KA, Dykstra LA, Lysle DT. Alterations of immune status induced by the sympathetic nervous system: immunomodulatory effects of DMPP alone and in combination with morphine. Brain Behav Immun 1993, 7:253-270. 10.1006/brbi.1993.1026, 8219413.
78. Fecho K, Dykstra LA, Lysle DT. Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine. J Pharmacol Exp Ther 1993, 265:1079-1087.
79. Hernandez MC, Flores LR, Bayer BM. Immunosuppression by morphine is mediated by central pathways. J Pharmacol Exp Ther 1993, 267:1336-1341.
80. Mellon RD, Bayer BM. Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism(s) of action. J Neuroimmunol 1998, 83:19-28. 10.1016/S0165-5728(97)00217-8, 9610669.
81. Saurer TB, Ijames SG, Lysle DT. Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity. J Neuroimmunol 2006, 177:18-26. 10.1016/j.jneuroim.2006.05.002, 16766046.
82. Saurer TB, Carrigan KA, Ijames SG, Lysle DT. Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell. J Neuroimmunol 2006, 173:3-11. 10.1016/j.jneuroim.2005.11.009, 16364456.
83. Saurer TB, Ijames SG, Carrigan KA, Lysle DT. Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation. Brain Behav Immun 2008, 22:89-97. 10.1016/j.bbi.2007.06.009, 17689049.
84. Chadzinska M, Hermsen T, Savelkoul HF, Verburg-van Kemenade BM. Cloning of opioid receptors in common carp (Cyprinus carpio L.) and their involvement in regulation of stress and immune response. Brain Behav Immun 2009, 23:257-266. 10.1016/j.bbi.2008.10.003, 18977430.
85. Zaborina O, Lepine F, Xiao G, Valuckaite V, Chen Y, Li T, Ciancio M, Zaborin A, Petrof EO, Turner JR, Rahme LG, Chang E, Alverdy JC. Dynorphin activates quorum sensing quinolone signaling in Pseudomonas aeruginosa. PLoS Pathog 2007, 3:e35. 10.1371/journal.ppat.0030035, 1828698,1828698, 17367209.
86. Wang J, Barke RA, Charboneau R, Schwendener R, Roy S. Morphine induces defects in early response of alveolar macrophages to Streptococcus pneumoniae by modulating TLR9-NF-kappa B signaling. J Immunol 2008, 180:3594-3600.
87. Xu J, Li PF, Liu XH, Li G. Morphine aggravates the apoptosis of simian immunodeficiency virus infected CEM x174 cells in the prolonged culture in vitro. Int Immunopharmacol 2004, 4:1805-1816. 10.1016/j.intimp.2004.07.025, 15531296.
88. Kumar R, Orsoni S, Norman L, Verma AS, Tirado G, Giavedoni LD, Staprans S, Miller GM, Buch SJ, Kumar A. Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques. Virology 2006, 354:192-206. 10.1016/j.virol.2006.06.020, 16876224.
89. Ocasio FM, Jiang Y, House SD, Chang SL. Chronic morphine accelerates the progression of lipopolysaccharide-induced sepsis to septic shock. J Neuroimmunol 2004, 149:90-100. 10.1016/j.jneuroim.2003.12.016, 15020069.
90. Martucci C, Panerai AE, Sacerdote P. Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses. Pain 2004, 110:385-392. 10.1016/j.pain.2004.04.020, 15275790.
91. Bryant HU, Bernton EW, Holaday JW. Morphine pellet-induced immunomodulation in mice: temporal relationships. J Pharmacol Exp Ther 1988, 245:913-920.
92. Bryant HU, Yoburn BC, Inturrisi CE, Bernton EW, Holaday JW. Morphine-induced immunomodulation is not related to serum morphine concentrations. Eur J Pharmacol 1988, 149:165-169. 10.1016/0014-2999(88)90057-X, 3260867.
93. Shavit Y, Terman GW, Lewis JW, Zane CJ, Gale RP, Liebeskind JC. Effects of footshock stress and morphine on natural killer lymphocytes in rats: studies of tolerance and cross-tolerance. Brain Res 1986, 372:382-385. 10.1016/0006-8993(86)91149-2, 3011211.
94. Avila AH, Alonzo NC, Bayer BM. Immune cell activity during the initial stages of withdrawal from chronic exposure to cocaine or morphine. J Neuroimmunol 2004, 147:109-113. 10.1016/j.jneuroim.2003.10.023, 14741439.
95. Pacifici R, Di Carlo S, Bacosi A, Zuccaro P. Macrophage functions in drugs of abuse-treated mice. Int J Immunopharmacol 1993, 15:711-716. 10.1016/0192-0561(93)90143-M, 8407054.
96. Risdahl JM, Peterson PK, Chao CC, Pijoan C, Molitor TW. Effects of morphine dependence on the pathogenesis of swine herpesvirus infection. J Infect Dis 1993, 167:1281-1287.
97. Kishioka S, Nishida S, Fukunaga Y, Yamamoto H. Quantitative properties of plasma corticosterone elevation induced by naloxone-precipitated withdrawal in morphine-dependent rats. Jpn J Pharmacol 1994, 66:257-263. 10.1254/jjp.66.257, 7869610.
98. West JP, Dykstra LA, Lysle DT. Immunomodulatory effects of morphine withdrawal in the rat are time dependent and reversible by clonidine. Psychopharmacology (Berl) 1999, 146:320-327. 10.1007/s002130051123, 10541733.
99. Rahim RT, Adler MW, Meissler JJ, Cowan A, Rogers TJ, Geller EB, Eisenstein TK. Abrupt or precipitated withdrawal from morphine induces immunosuppression. J Neuroimmunol 2002, 127:88-95. 10.1016/S0165-5728(02)00103-0, 12044979.
100. Wang X, Douglas SD, Peng JS, Zhou DJ, Wan Q, Ho WZ. An in vitro model of morphine withdrawal manifests the enhancing effect on human immunodeficiency virus infection of human T lymphocytes through the induction of substance P. Am J Pathol 2006, 169:1663-1670. 10.2353/ajpath.2006.060358, 1780221, 17071590.
101. Wang CQ, Li Y, Douglas SD, Wang X, Metzger DS, Zhang T, Ho WZ. Morphine withdrawal enhances hepatitis C virus replicon expression. Am J Pathol 2005, 167:1333-1340. 1603791, 16251417.
102. Feng P, Meissler JJ, Adler MW, Eisenstein TK. Morphine withdrawal sensitizes mice to lipopolysaccharide: elevated TNF-alpha and nitric oxide with decreased IL-12. J Neuroimmunol 2005, 164:57-65. 10.1016/j.jneuroim.2005.03.017, 15913793.
103. Feng P, Wilson QM, Meissler JJ, Adler MW, Eisenstein TK. Increased sensitivity to Salmonella enterica serovar Typhimurium infection in mice undergoing withdrawal from morphine is associated with suppression of interleukin-12. Infect Immun 2005, 73:7953-7959. 10.1128/IAI.73.12.7953-7959.2005, 1307081, 16299287.
104. Feng P, Truant AL, Meissler JJ, Gaughan JP, Adler MW, Eisenstein TK. Morphine withdrawal lowers host defense to enteric bacteria: spontaneous sepsis and increased sensitivity to oral Salmonella enterica serovar Typhimurium infection. Infect Immun 2006, 74:5221-5226. 10.1128/IAI.00208-06, 1594820, 16926415.
105. Zavala F, Taupin V, Descamps-Latscha B. In vivo treatment with benzodiazepines inhibits murine phagocyte oxidative metabolism and production of interleukin 1, tumor necrosis factor and interleukin-6. J Pharmacol Exp Ther 1990, 255:442-450.
106. Nishina K, Akamatsu H, Mikawa K, Shiga M, Maekawa N, Obara H, Niwa Y. The inhibitory effects of thiopental, midazolam, and ketamine on human neutrophil functions. Anesth Analg 1998, 86:159-165. 10.1097/00000539-199801000-00032, 9428872.
107. Fujimoto T, Nishiyama T, Hanaoka K. Inhibitory effects of intravenous anesthetics on mast cell function. Anesth Analg 2005, 101:1054-1059. 10.1213/01.ane.0000166955.97368.80, 16192519.
108. Ugaz EM, Pinheiro SR, Guerra JL, Palermo-Neto J. Effects of prenatal diazepam treatment on Mycobacterium bovis-induced infection in hamsters. Immunopharmacology 1999, 41:209-217. 10.1016/S0162-3109(99)00031-4, 10428649.
109. Righi DA, Pinheiro SR, Guerra JL, Palermo-Neto J. Effects of diazepam on Mycobacterium bovis-induced infection in hamsters. Braz J Med Biol Res 1999, 32:1145-1153. 10.1590/S0100-879X1999000900014, 10464392.
110. Takaono M, Yogosawa T, Okawa-Takatsuji M, Aotsuka S. Effects of intravenous anesthetics on interleukin (IL)-6 and IL-10 production by lipopolysaccharide-stimulated mononuclear cells from healthy volunteers. Acta Anaesthesiol Scand 2002, 46:176-179. 10.1034/j.1399-6576.2002.460209.x, 11942866.
111. Memis D, Hekimoglu S, Vatan I, Yandim T, Yuksel M, Sut N. Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients. Br J Anaesth 2007, 98:550-552. 10.1093/bja/aem017, 17363413.
112. Inada T, Taniuchi S, Shingu K, Kobayashi Y, Fujisawa J, Nakao S. Propofol depressed neutrophil hydrogen peroxide production more than midazolam, whereas adhesion molecule expression was minimally affected by both anesthetics in rats with abdominal sepsis. Anesth Analg 2001, 92:437-441. 10.1097/00000539-200102000-00030, 11159247.
113. Yu HP, Lui PW, Hwang TL, Yen CH, Lau YT. Propofol improves endothelial dysfunction and attenuates vascular superoxide production in septic rats. Crit Care Med 2006, 34:453-460. 10.1097/01.CCM.0000198530.68343.21, 16424728.
114. Hsu BG, Yang FL, Lee RP, Peng TC, Chen HI. Effects of post-treatment with low-dose propofol on inflammatory responses to lipopolysaccharide-induced shock in conscious rats. Clin Exp Pharmacol Physiol 2005, 32:24-29. 10.1111/j.1440-1681.2005.04155.x, 15730430.
115. Takao Y, Mikawa K, Nishina K, Obara H. Attenuation of acute lung injury with propofol in endotoxemia. Anesth Analg 2005, 100:810-816. 10.1213/01.ANE.0000144775.19385.8C, 15728072.
116. Knaus AE, Muthig V, Schickinger S, Moura E, Beetz N, Gilsbach R, Hein L. Alpha2-adrenoceptor subtypes--unexpected functions for receptors and ligands derived from gene-targeted mouse models. Neurochem Int 2007, 51:277-281. 10.1016/j.neuint.2007.06.036, 17664025.
117. Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, Shintani AK, Thompson JL, Jackson JC, Deppen SA, Stiles RA, Dittus RS, Bernard GR, Ely EW. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007, 298:2644-2653. 10.1001/jama.298.22.2644, 18073360.
118. Martin J, Parsch A, Franck M, Wernecke KD, Fischer M, Spies C. Practice of sedation and analgesia in German intensive care units: results of a national survey. Crit Care 2005, 9:R117-R123. 10.1186/cc3035, 1175921, 15774043.
119. Kim MH, Hahn TH. The effect of clonidine pretreatment on the perioperative proinflammatory cytokines, cortisol, and ACTH responses in patients undergoing total abdominal hysterectomy. Anesth Analg 2000, 90:1441-1444. 10.1097/00000539-200006000-00035, 10825337.
120. Taniguchi T, Kurita A, Kobayashi K, Yamamoto K, Inaba H. Dose- and time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats. J Anesth 2008, 22:221-228. 10.1007/s00540-008-0611-9, 18685927.
121. Hofer S, Steppan J, Wagner T, Funke B, Lichtenstern C, Martin E, Graf BM, Bierhaus A, Weigand MA. Central sympatholytics prolong survival in experimental sepsis. Crit Care 2009, 13:R11. 10.1186/cc7709, 2688128, 19196475.
122. Rosas-Ballina M, Ochani M, Parrish WR, Ochani K, Harris YT, Huston JM, Chavan S, Tracey KJ. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci USA 2008, 105:11008-11013. 10.1073/pnas.0803237105, 2504833, 18669662.
123. Ulloa L, Deitch EA. Neuroimmune perspectives in sepsis. Crit Care 2009, 13:133. 10.1186/cc7758, 19439052.
124. Correa-Sales C, Tosta CE, Rizzo LV. The effects of anesthesia with thiopental on T lymphocyte responses to antigen and mitogens in vivo and in vitro. Int J Immunopharmacol 1997, 19:117-128. 10.1016/S0192-0561(97)00003-9, 9278182.
125. Yang FL, Li CH, Hsu BG, Tsai NM, Lin SZ, Harn HJ, Chen HI, Liao KW, Lee RP. The reduction of tumor necrosis factor-alpha release and tissue damage by pentobarbital in the experimental endotoxemia model. Shock 2007, 28:309-316.
126. Ploppa A, Kiefer RT, Nohe B, Haeberle HA, Dieterich HJ, Unertl KE, Krueger WA. Dose-dependent influence of barbiturates but not of propofol on human leukocyte phagocytosis of viable Staphylococcus aureus. Crit Care Med 2006, 34:478-483. 10.1097/01.CCM.0000199067.71968.6E, 16424731.
127. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000, 342:1471-1477. 10.1056/NEJM200005183422002, 10816184.
128. Girard TD, Kress JP, Fuchs BD, Thomason JW, Schweickert WD, Pun BT, Taichman DB, Dunn JG, Pohlman AS, Kinniry PA, Jackson JC, Canonico AE, Light RW, Shintani AK, Thompson JL, Gordon SM, Hall JB, Dittus RS, Bernard GR, Ely EW. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008, 371:126-134. 10.1016/S0140-6736(08)60105-1, 18191684.
129. Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, Spears L, Miller M, Franczyk M, Deprizio D, Schmidt GA, Bowman A, Barr R, McCallister KE, Hall JB, Kress JP. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009, 373:1874-1882. 10.1016/S0140-6736(09)60658-9, 19446324.
130. Papadimos TJ, Hensley SJ, Duggan JM, Khuder SA, Borst MJ, Fath JJ, Oakes LR, Buchman D. Implementation of the "FASTHUG" concept decreases the incidence of ventilator-associated pneumonia in a surgical intensive care unit. Patient Saf Surg 2008, 2:3. 10.1186/1754-9493-2-3, 2276483, 18271952.
131. Blamoun J, Alfakir M, Rella ME, Wojcik JM, Solis RA, Anees KM, DeBari VA. Efficacy of an expanded ventilator bundle for the reduction of ventilator-associated pneumonia in the medical intensive care unit. Am J Infect Control 2009, 37:172-175. 10.1016/j.ajic.2008.05.010, 18945515.
132. Resar R, Pronovost P, Haraden C, Simmonds T, Rainey T, Nolan T. Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm J Qual Patient Saf 2005, 31:243-248.
133. Berriel-Cass D, Adkins FW, Jones P, Fakih MG. Eliminating nosocomial infections at Ascension Health. Jt Comm J Qual Patient Saf 2006, 32:612-620.
134. Youngquist P, Carroll M, Farber M, Macy D, Madrid P, Ronning J, Susag A. Implementing a ventilator bundle in a community hospital. Jt Comm J Qual Patient Saf 2007, 33:219-225.
135. Unahalekhaka A, Jamulitrat S, Chongsuvivatwong V, Ovretveit J. Using a collaborative to reduce ventilator-associated pneumonia in Thailand. Jt Comm J Qual Patient Saf 2007, 33:387-394.
136. Wip C, Napolitano L. Bundles to prevent ventilator-associated pneumonia: how valuable are they?. Curr Opin Infect Dis 2009, 22:159-166. 10.1097/QCO.0b013e3283295e7b, 19276975.
137. Brook AD, Ahrens TS, Schaiff R, Prentice D, Sherman G, Shannon W, Kollef MH. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999, 27:2609-2615. 10.1097/00003246-199912000-00001, 10628598.
138. Arias-Rivera S, Sanchez-Sanchez MM, Santos-Diaz R, Gallardo-Murillo J, Sanchez-Izquierdo R, Frutos-Vivar F, Ferguson ND, Esteban A. Effect of a nursing-implemented sedation protocol on weaning outcome. Crit Care Med 2008, 36:2054-2060. 10.1097/CCM.0b013e31817bfd60, 18552689.
139. de Wit M, Gennings C, Jenvey WI, Epstein SK. Randomized trial comparing daily interruption of sedation and nursing-implemented sedation algorithm in medical intensive care unit patients. Crit Care 2008, 12:R70. 10.1186/cc6908, 2481461, 18492267.
140. Elliott R, McKinley S, Aitken LM, Hendrikz J. The effect of an algorithm-based sedation guideline on the duration of mechanical ventilation in an Australian intensive care unit. Intensive Care Med 2006, 32:1506-1514. 10.1007/s00134-006-0309-0, 16896847.
141. Bucknall TK, Manias E, Presneill JJ. A randomized trial of protocol-directed sedation management for mechanical ventilation in an Australian intensive care unit. Crit Care Med 2008, 36:1444-1450. 10.1097/CCM.0b013e318168f82d, 18434914.
142. Quenot JP, Ladoire S, Devoucoux F, Doise JM, Cailliod R, Cunin N, Aube H, Blettery B, Charles PE. Effect of a nurse-implemented sedation protocol on the incidence of ventilator-associated pneumonia. Crit Care Med 2007, 35:2031-2036. 10.1097/01.ccm.0000282733.83089.4d, 17855817.
143. von Dossow V, Luetz A, Haas A, Sawitzki B, Wernecke KD, Volk HD, Spies CD. Effects of remifentanil and fentanyl on the cell-mediated immune response in patients undergoing elective coronary artery bypass graft surgery. J Int Med Res 2008, 36:1235-1247.
144. Arya V, Ramji S. Midazolam sedation in mechanically ventilated newborns: a double blind randomized placebo controlled trial. Indian Pediatr 2001, 38:967-972.
145. Helmy SA, Al Attiyah RJ. The immunomodulatory effects of prolonged intravenous infusion of propofol versus midazolam in critically ill surgical patients. Anaesthesia 2001, 56:4-8. 10.1046/j.1365-2044.2001.01713.x, 11167428.
146. Kress JP, O'Connor MF, Pohlman AS, Olson D, Lavoie A, Toledano A, Hall JB. Sedation of critically ill patients during mechanical ventilation. A comparison of propofol and midazolam. Am J Respir Crit Care Med 1996, 153:1012-1018.
147. Liatsi D, Tsapas B, Pampori S, Tsagourias M, Pneumatikos I, Matamis D. Respiratory, metabolic and hemodynamic effects of clonidine in ventilated patients presenting with withdrawal syndrome. Intensive Care Med 2009, 35:275-281. 10.1007/s00134-008-1251-0, 18709354.
148. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, Whitten P, Margolis BD, Byrne DW, Ely EW, Rocha MG. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009, 301:489-499. 10.1001/jama.2009.56, 19188334.
149. Nadal P, Nicolas JM, Font C, Vilella A, Nogue S. Pneumonia in ventilated head trauma patients: the role of thiopental therapy. Eur J Emerg Med 1995, 2:14-16. 10.1097/00063110-199503000-00004, 9422174.
150. Becker G, Blum HE. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus. Lancet 2009, 373:1198-1206. 10.1016/S0140-6736(09)60139-2, 19217656.
151. Thomas J, Karver S, Cooney GA, Chamberlain BH, Watt CK, Slatkin NE, Stambler N, Kremer AB, Israel RJ. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008, 358:2332-2343. 10.1056/NEJMoa0707377, 18509120.